Get a free CVR in the Aratana Therapeutics acquisition | Value Investing News

Get a free CVR in the Aratana Therapeutics acquisition

  • Last Friday Aratana Therapeutics (NASDAQ:PETX) announced that it would be acquired by Elanco Animal Health (NYSE:ELAN).
  • Elanco will pay 0.1481 shares of common stock – worth $4.85 at current market prices – while Aratana is trading at $4.79 for a spread of just 1.2%.
  • While it’s a low-risk deal that should close soon, that’s not enough to get excited about.
Rating: 
No votes yet
Article Link: 
Shared Count: 
0
Value Score: 
0
Category: